QIAGEN and Myriad Genetics announced they will develop a globally distributable kit-based test for analyzing Homologous Recombination Deficiency (HRD) status. This next-generation sequencing (NGS)...
Helix, the leading population genomics and viral surveillance company in the nation, announced a global strategic partnership with QIAGEN N.V., the leading global provider...